Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$383K Buy
1,058
+162
+18% +$55.5K ﹤0.01% 223
2026
Q1
$315K Buy
896
+158
+21% +$56.3K ﹤0.01% 220
2025
Q4
$242K Sell
738
-1
-0.1% -$317 ﹤0.01% 238
2025
Q3
$209K Buy
+739
New +$214K ﹤0.01% 255
2025
Q2
Sell
-771
Closed -$240K 248
2025
Q1
$240K Sell
771
-50
-6% -$14.8K 0.01% 212
2024
Q4
$214K Buy
821
+73
+10% +$21.7K ﹤0.01% 243
2024
Q3
$241K Buy
+748
New +$245K ﹤0.01% 218
2021
Q3
$42K Hold
199
0.01% 214
2021
Q2
$49K Hold
199
0.01% 205
2021
Q1
$50K Hold
199
0.01% 188
2020
Q4
$50K Buy
+199
New +$45.9K 0.02% 165

Other funds holding AMGN

PGIM Custom Harvest's AMGN Position: Q2 2026 in Review

PGIM Custom Harvest increased its Amgen (AMGN) stake by 18% in Q2 2026, buying an estimated $55.5K and bringing the position to 1,058 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #223.

PGIM Custom Harvest first reported a position in AMGN in Q4 2020 and has held it in 11 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • PGIM Custom Harvest held 1,058 shares of Amgen worth $383K as of Q2 2026.
  • PGIM Custom Harvest bought 162 Amgen shares in Q2 2026, an estimated $55.5K.
  • Amgen made up ﹤0.01% of PGIM Custom Harvest's portfolio in Q2 2026, its #223 holding.
  • PGIM Custom Harvest first reported a position in Amgen in Q4 2020 and has held it in 11 quarters since.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on PGIM Custom Harvest's 13F filing for Q2 2026, filed 13 Aug 2026.